|
Market Closed -
Nasdaq
16:00:00 2026-10-29 EDT
|
5-day change | 1st Jan Change | ||
| 7.795 USD | -2.32% |
|
+7.96% | +46.06% |
Company Valuation: Immunic, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 251.2 | 62.1 | 67.72 | 90.08 | 64.2 | 108.9 | - | - |
| Change | - | -75.28% | 9.04% | 33.02% | -28.73% | 69.61% | - | - |
| Enterprise Value (EV) 1 | 176.3 | -54.27 | 21.04 | 90.08 | 64.2 | -171 | -294.9 | 108.9 |
| Change | - | -130.78% | 138.77% | 328.05% | -28.73% | -366.4% | -72.45% | 136.92% |
| P/E | -2.44x | -0.37x | -0.71x | -1x | -0.86x | -2.22x | -3.36x | -3.28x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | 0.1x | 0x | 0x | 0x | 0.1x | 0.1x | -1.35x |
| Capitalization / Revenue | - | - | - | - | - | - | - | 1.86x |
| EV / Revenue | - | - | - | - | - | - | - | 1.86x |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| EV / EBIT | -2.34x | 0.63x | -0.21x | -0.92x | -0.62x | 1.21x | 1.9x | -0.8x |
| EV / FCF | - | - | - | -1.06x | -0.75x | 1.4x | 2.1x | -0.86x |
| FCF Yield | - | - | - | -94.4% | -134% | 71.3% | 47.6% | -117% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -39.3 | -37.8 | -21.1 | -10 | -6.2 | -3.595 | -2.374 | -2.431 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | - | - | - | - | - | - | - | 58.44 |
| EBITDA | - | - | - | - | - | - | - | - |
| EBIT 1 | -75.42 | -86.52 | -99.22 | -98.05 | -103.2 | -140.8 | -154.9 | -135.9 |
| Net income 1 | -92.94 | -120.4 | -93.61 | -100.5 | -97.17 | -138 | -149.4 | -141.8 |
| Net Debt 1 | -74.88 | -116.4 | -46.67 | - | - | -279.9 | -403.8 | - |
| Reference price 2 | 95.700 | 14.000 | 15.000 | 10.000 | 5.337 | 7.980 | 7.980 | 7.980 |
| Nbr of stocks (in thousands) | 2,625 | 4,436 | 4,515 | 9,008 | 12,028 | 13,644 | - | - |
| Announcement Date | 2/24/22 | 2/23/23 | 2/22/24 | 3/31/25 | 2/26/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.22x | - | - | - | 109M | |
| 16.92x | 6.39x | 12.26x | 1.77% | 64.14B | |
| 30.57x | 8.11x | 26.59x | 0.05% | 55.53B | |
| 36.68x | 6.52x | 19.45x | 0.88% | 53.03B | |
| 35.39x | 3.41x | 14.74x | -.--% | 45.99B | |
| 49.25x | 5.68x | 31.09x | -.--% | 42.45B | |
| -19.59x | 189.6x | -20.86x | -.--% | 40.45B | |
| 31.7x | 8.06x | 20.96x | 0.41% | 32.25B | |
| 47.12x | 8.37x | 28.08x | -.--% | 34.47B | |
| 27.96x | 5.9x | 15.29x | -.--% | 24.23B | |
| Average | 25.38x | 26.89x | 16.40x | 0.34% | 39.27B | |
| Weighted average by Cap. | 27.96x | 25.38x | 16.46x | 0.45% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- IMUX Stock
- Valuation Immunic, Inc.
Select your edition
All financial news and data tailored to specific country editions
